45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published: assessment threshold met
●Gross / standard charges: assessment threshold met
●Discounted cash price: assessment threshold met
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
4,137
Insurances with rates
27
CPT / HCPCS codes
390
Most expensive procedures (gross)
189201
$135,511
RAVULIZUMAB-CWVZ 1100 MG/11ML IV SOLN
Gross
$135,511
Multiple sclerosis & cerebellar ataxia without c
$119,963
Multiple sclerosis & cerebellar ataxia without complications
Gross
$119,963
Hernia procedures except inguinal & femoral with
$119,721
Hernia procedures except inguinal & femoral with major complications
Gross
$119,721
169866
$119,120
OCRELIZUMAB 300 MG/10ML IV SOLN
Gross
$119,120
Major small & large bowel procedures with major
$100,149
Major small & large bowel procedures with major complications
Gross
$100,149
Major small & large bowel procedures with compli
$84,382
Major small & large bowel procedures with complications
Gross
$84,382
163008
$66,883
ATEZOLIZUMAB 1200 MG/20ML IV SOLN
Gross
$66,883
Stomach, esophageal & duodenal proc without comp
$65,680
Stomach, esophageal & duodenal proc without complications
Gross
$65,680
178093
$63,048
CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN
Gross
$63,048
Nutritional & misc metabolic disorders with majo
$59,652
Nutritional & misc metabolic disorders with major complications
Gross
$59,652
Amputation of lower limb for endocrine, nutritio
$58,371
Amputation of lower limb for endocrine, nutritional, & metabolic disorder with complications
Gross
$58,371
106242
$52,255
IPILIMUMAB 50 MG/10ML IV SOLN
Gross
$52,255
146304
$49,705
OBINUTUZUMAB 1000 MG/40ML IV SOLN
Gross
$49,705
Other digestive system diagnoses with major comp
$49,000
Other digestive system diagnoses with major complications
Gross
$49,000
187652
$47,611
LURBINECTEDIN 4 MG IV SOLR
Gross
$47,611
173195
$45,840
NIVOLUMAB 240 MG/24ML IV SOLN
Gross
$45,840
Trauma to the skin, subcut tiss & breast with ma
$40,103
Trauma to the skin, subcut tiss & breast with major complications
Gross
$40,103
118659
$39,362
PERTUZUMAB 420 MG/14ML IV SOLN
Gross
$39,362
122698
$36,839
ADO-TRASTUZUMAB EMTANSINE 160 MG IV SOLR
Gross
$36,839
24436
$36,394
OCTREOTIDE ACETATE 30 MG IM KIT
Gross
$36,394
152774
$34,717
PEMBROLIZUMAB 100 MG/4ML IV SOLN
Gross
$34,717
Disorders of pancreas except malignancy with com
$33,538
Disorders of pancreas except malignancy with complications
Gross
$33,538
Osteomyelitis with complications
$33,434
Osteomyelitis with complications
Gross
$33,434
193183
$31,398
ANIFROLUMAB-FNIA 300 MG/2ML IV SOLN
Gross
$31,398
Chronic Lung Disease with major complications
$31,303
Chronic Lung Disease with major complications
Gross
$31,303
Infectious & parasitic diseases w O.R. procedure
$29,788
Infectious & parasitic diseases w O.R. procedure with complications
Gross
$29,788
Skin grafts & wound debridement for endocrine, n
$29,269
Skin grafts & wound debridement for endocrine, nutritional & metabolic disorder with major complicat
Gross
$29,269
Connective tissue disorders with complications
$28,049
Connective tissue disorders with complications
Gross
$28,049
Disorders of liver except malignancy with compli
$27,466
Disorders of liver except malignancy with complications
Gross
$27,466
155757
$27,110
RITUXIMAB 500 MG/50ML IV SOLN
Gross
$27,110
195400
$25,211
TEZEPELUMAB-EKKO 210 MG/1.91ML SUBQ SOSY
Gross
$25,211
170567
$24,785
DURVALUMAB 500 MG/10ML IV SOLN
Gross
$24,785
24435
$24,305
OCTREOTIDE ACETATE 20 MG IM KIT
Gross
$24,305
Infection of the skin
$24,043
Infection of the skin
Gross
$24,043
122697
$23,025
ADO-TRASTUZUMAB EMTANSINE 100 MG IV SOLR
Gross
$23,025
155763
$22,861
PEGFILGRASTIM 6 MG/0.6ML SUBQ PSKT
Gross
$22,861
155762
$22,861
PEGFILGRASTIM 6 MG/0.6ML SUBQ SOSY
Gross
$22,861
Respiratory infections and inflammations with ma
$22,035
Respiratory infections and inflammations with major complications
Gross
$22,035
Esophagitis, gastroent & misc digest disorders w
$19,787
Esophagitis, gastroent & misc digest disorders with major complications
Gross
$19,787
152623
$19,100
NIVOLUMAB 100 MG/10ML IV SOLN
Gross
$19,100
Major chest trauma without complications
$18,880
Major chest trauma without complications
Gross
$18,880
105846
$18,397
BEVACIZUMAB 400 MG/16ML IV SOLN
Gross
$18,397
Other multiple significant trauma without compli
$18,187
Other multiple significant trauma without complications
Gross
$18,187
Seizures with major complications
$18,174
Seizures with major complications
Gross
$18,174
156872
$17,861
ELOTUZUMAB 400 MG IV SOLR
Gross
$17,861
110254
$17,429
DENOSUMAB 120 MG/1.7ML SUBQ SOLN
Gross
$17,429
9002
$17,317
ALTEPLASE 100 MG IV SOLR
Gross
$17,317
156697
$16,975
DARATUMUMAB 400 MG/20ML IV SOLN
Gross
$16,975
Pneumothorax with complications
$16,041
Pneumothorax with complications
Gross
$16,041
Pneumonia with major complications
$15,315
Pneumonia with major complications
Gross
$15,315
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 189201 | RAVULIZUMAB-CWVZ 1100 MG/11ML IV SOLN | $135,511 | $135,511 | — | — | 2 |
| Multiple sclerosis & cerebellar ataxia without c | Multiple sclerosis & cerebellar ataxia without complications | $119,963 | $119,963 | — | — | 3 |
| Hernia procedures except inguinal & femoral with | Hernia procedures except inguinal & femoral with major complications | $119,721 | $119,721 | — | — | 1 |
| 169866 | OCRELIZUMAB 300 MG/10ML IV SOLN | $119,120 | $119,120 | — | — | 2 |
| Major small & large bowel procedures with major | Major small & large bowel procedures with major complications | $100,149 | $100,149 | — | — | 1 |
| Major small & large bowel procedures with compli | Major small & large bowel procedures with complications | $84,382 | $84,382 | — | — | 2 |
| 163008 | ATEZOLIZUMAB 1200 MG/20ML IV SOLN | $66,883 | $66,883 | — | — | 3 |
| Stomach, esophageal & duodenal proc without comp | Stomach, esophageal & duodenal proc without complications | $65,680 | $65,680 | — | — | 1 |
| 178093 | CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN | $63,048 | $63,048 | — | — | 1 |
| Nutritional & misc metabolic disorders with majo | Nutritional & misc metabolic disorders with major complications | $59,652 | $59,652 | — | — | 4 |
| Amputation of lower limb for endocrine, nutritio | Amputation of lower limb for endocrine, nutritional, & metabolic disorder with complications | $58,371 | $58,371 | — | — | 2 |
| 106242 | IPILIMUMAB 50 MG/10ML IV SOLN | $52,255 | $52,255 | — | — | 2 |
| 146304 | OBINUTUZUMAB 1000 MG/40ML IV SOLN | $49,705 | $49,705 | — | — | 1 |
| Other digestive system diagnoses with major comp | Other digestive system diagnoses with major complications | $49,000 | $49,000 | — | — | 4 |
| 187652 | LURBINECTEDIN 4 MG IV SOLR | $47,611 | $47,611 | — | — | 1 |
| 173195 | NIVOLUMAB 240 MG/24ML IV SOLN | $45,840 | $45,840 | — | — | 8 |
| Trauma to the skin, subcut tiss & breast with ma | Trauma to the skin, subcut tiss & breast with major complications | $40,103 | $40,103 | — | — | 1 |
| 118659 | PERTUZUMAB 420 MG/14ML IV SOLN | $39,362 | $39,362 | — | — | 1 |
| 122698 | ADO-TRASTUZUMAB EMTANSINE 160 MG IV SOLR | $36,839 | $36,839 | — | — | 3 |
| 24436 | OCTREOTIDE ACETATE 30 MG IM KIT | $36,394 | $36,394 | — | — | 4 |
| 152774 | PEMBROLIZUMAB 100 MG/4ML IV SOLN | $34,717 | $34,717 | — | — | 14 |
| Disorders of pancreas except malignancy with com | Disorders of pancreas except malignancy with complications | $33,538 | $33,538 | — | — | 4 |
| Osteomyelitis with complications | Osteomyelitis with complications | $33,434 | $33,434 | — | — | 3 |
| 193183 | ANIFROLUMAB-FNIA 300 MG/2ML IV SOLN | $31,398 | $31,398 | — | — | 2 |
| Chronic Lung Disease with major complications | Chronic Lung Disease with major complications | $31,303 | $31,303 | — | — | 2 |
| Infectious & parasitic diseases w O.R. procedure | Infectious & parasitic diseases w O.R. procedure with complications | $29,788 | $29,788 | — | — | 1 |
| Skin grafts & wound debridement for endocrine, n | Skin grafts & wound debridement for endocrine, nutritional & metabolic disorder with major complicat | $29,269 | $29,269 | — | — | 1 |
| Connective tissue disorders with complications | Connective tissue disorders with complications | $28,049 | $28,049 | — | — | 3 |
| Disorders of liver except malignancy with compli | Disorders of liver except malignancy with complications | $27,466 | $27,466 | — | — | 3 |
| 155757 | RITUXIMAB 500 MG/50ML IV SOLN | $27,110 | $27,110 | — | — | 4 |
| 195400 | TEZEPELUMAB-EKKO 210 MG/1.91ML SUBQ SOSY | $25,211 | $25,211 | — | — | 2 |
| 170567 | DURVALUMAB 500 MG/10ML IV SOLN | $24,785 | $24,785 | — | — | 4 |
| 24435 | OCTREOTIDE ACETATE 20 MG IM KIT | $24,305 | $24,305 | — | — | 4 |
| Infection of the skin | Infection of the skin | $24,043 | $24,043 | — | — | 4 |
| 122697 | ADO-TRASTUZUMAB EMTANSINE 100 MG IV SOLR | $23,025 | $23,025 | — | — | 3 |
| 155763 | PEGFILGRASTIM 6 MG/0.6ML SUBQ PSKT | $22,861 | $22,861 | — | — | 9 |
| 155762 | PEGFILGRASTIM 6 MG/0.6ML SUBQ SOSY | $22,861 | $22,861 | — | — | 9 |
| Respiratory infections and inflammations with ma | Respiratory infections and inflammations with major complications | $22,035 | $22,035 | — | — | 2 |
| Esophagitis, gastroent & misc digest disorders w | Esophagitis, gastroent & misc digest disorders with major complications | $19,787 | $19,787 | — | — | 4 |
| 152623 | NIVOLUMAB 100 MG/10ML IV SOLN | $19,100 | $19,100 | — | — | 8 |
| Major chest trauma without complications | Major chest trauma without complications | $18,880 | $18,880 | — | — | 2 |
| 105846 | BEVACIZUMAB 400 MG/16ML IV SOLN | $18,397 | $18,397 | — | — | 8 |
| Other multiple significant trauma without compli | Other multiple significant trauma without complications | $18,187 | $18,187 | — | — | 1 |
| Seizures with major complications | Seizures with major complications | $18,174 | $18,174 | — | — | 1 |
| 156872 | ELOTUZUMAB 400 MG IV SOLR | $17,861 | $17,861 | — | — | 1 |
| 110254 | DENOSUMAB 120 MG/1.7ML SUBQ SOLN | $17,429 | $17,429 | — | — | 17 |
| 9002 | ALTEPLASE 100 MG IV SOLR | $17,317 | $17,317 | — | — | 8 |
| 156697 | DARATUMUMAB 400 MG/20ML IV SOLN | $16,975 | $16,975 | — | — | 2 |
| Pneumothorax with complications | Pneumothorax with complications | $16,041 | $16,041 | — | — | 1 |
| Pneumonia with major complications | Pneumonia with major complications | $15,315 | $15,315 | — | — | 4 |
Showing top 50 of 4,137 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.